Review





Similar Products

96
Proteintech rabbit polyclonal anti ampk alpha 1
Rabbit Polyclonal Anti Ampk Alpha 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPK+alpha+1+Antibody/pm42976855-323-280-285
Average 96 stars, based on 1 article reviews
rabbit polyclonal anti ampk alpha 1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc phospho ampk
Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) <t>phosphorylated</t> <t>SMAD2/3</t> (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated <t>AMPK</t> (p-AMPK) and total AMPK, ( d ) phosphorylated ERK1/2 (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.
Phospho Ampk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/Phospho-AMPKalpha+(Thr172)+Antibody/pmc13765516-160-34-35
Average 96 stars, based on 1 article reviews
phospho ampk - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc phospho ampk thr172
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Phospho Ampk Thr172, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/LC3A%2FB+Antibody/pmc13748706-58-25-27
Average 97 stars, based on 1 article reviews
phospho ampk thr172 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Proteintech anti ampk
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Anti Ampk, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPK+alpha+1+Antibody/pm43000378-33-16-23
Average 96 stars, based on 1 article reviews
anti ampk - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Proteintech ampk alpha antibody 141
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Ampk Alpha Antibody 141, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPK+alpha+Antibody/pm42998802-62-55-59
Average 95 stars, based on 1 article reviews
ampk alpha antibody 141 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Proteintech ampkα
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Ampkα, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPK+alpha+1+Antibody/pmc13757693-95-13-14
Average 96 stars, based on 1 article reviews
ampkα - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc p ampk
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
P Ampk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/Phospho-AMPKalpha+(Thr172)+Rabbit+mAb/pm42992988-332-29-30
Average 98 stars, based on 1 article reviews
p ampk - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

96
Proteintech phospho ampk
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Phospho Ampk, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPK+alpha+1+Antibody/pm42982110-138-23-25
Average 96 stars, based on 1 article reviews
phospho ampk - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc anti phospho ampk thr172
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Anti Phospho Ampk Thr172, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/Phospho-AMPKalpha+(Thr172)+Rabbit+mAb/10__1016_slash_j__jrras__2026__102799-131-26-29
Average 98 stars, based on 1 article reviews
anti phospho ampk thr172 - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc applicat ion ampkα ampk alpha antibody rabbit polyclonal cell signalingtechnology 2532 wb p ampkα phospho ampk alpha thr172
Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and <t>T172</t> and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.
Applicat Ion Ampkα Ampk Alpha Antibody Rabbit Polyclonal Cell Signalingtechnology 2532 Wb P Ampkα Phospho Ampk Alpha Thr172, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ampk/AMPKalpha+Antibody/pm42980460-5-0-8
Average 97 stars, based on 1 article reviews
applicat ion ampkα ampk alpha antibody rabbit polyclonal cell signalingtechnology 2532 wb p ampkα phospho ampk alpha thr172 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

Image Search Results


Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) phosphorylated ERK1/2 (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Journal: Molecules

Article Title: Atractylenolide III Attenuates TGF-β1-Induced Myofibroblast Differentiation in Primary Human Corneal Keratocytes

doi: 10.3390/molecules31214040

Figure Lengend Snippet: Effects of ATL-III on TGF-β1-induced intracellular signaling in primary human corneal keratocytes. Primary human corneal keratocytes were treated with TGF-β1 (10 ng/mL) alone or in combination with ATL-III (50 or 100 µM) for 1 h. Representative Western blot images and corresponding densitometric analyses are shown for ( a ) phosphorylated SMAD2/3 (p-SMAD2/3) and total SMAD2/3, ( b ) phosphorylated p38 MAPK (p-p38 MAPK) and total p38 MAPK, ( c ) phosphorylated AMPK (p-AMPK) and total AMPK, ( d ) phosphorylated ERK1/2 (p-ERK1/2) and total ERK1/2, and ( e ) phosphorylated NF-κB (p-NF-κB) and total NF-κB. Phosphorylated protein levels were normalized to their corresponding total protein levels and expressed relative to the untreated control group. n = 3 independent experiments. Statistical significance was determined by one-way ANOVA followed by Dunnett’s multiple-comparison test, with the TGF-β1-treated group used as the reference group for treatment comparisons. * p < 0.05, ** p < 0.01, and **** p < 0.0001.

Article Snippet: Following transfer, membranes were blocked with 5% BSA for 30 min and incubated overnight at 4 °C with primary antibodies against the following proteins: phospho-SMAD2/3 (Cellsignaling, catalog no. 8828), SMAD2/3 (Cellsignaling, catalog no. 3102), phospho-AMPK (Cellsignaling, catalog no. 2531), AMPK (Cellsignaling, catalog no. 2532), phospho-NF-κB (Cellsignaling, catalog no. 3033), NF-κB (Cellsignaling, catalog no. 8242), phospho-p38 MAPK (Cellsignaling, catalog no. 9211), p38 MAPK (Cellsignaling, catalog no. 9212), phospho-ERK1/2 (Cellsignaling, catalog no. 9101), ERK1/2 (Cellsignaling, catalog no. 9102), α-SMA (Cellsignaling, catalog no. 14968), GAPDH (Cellsignaling, catalog no. 5174).

Techniques: Western Blot, Control, Comparison

Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and T172 and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.

Journal: Aging Cell

Article Title: Impaired Exercise‐Induced Mitophagy in Aged Muscle Coincides With Altered mitoAMPKα in Male Mice

doi: 10.1111/acel.70827

Figure Lengend Snippet: Loss of mitoAMPKα with age may be due to Trim72‐mediated degradation. (A) Venn diagram of significant phosphorylation events in plantaris muscle following work‐normalized acute exercise. Left: Downregulated with exercise. Right: Upregulated with exercise. (B) KEGG pathway analysis of significantly upregulated phosphorylation events unique to 24‐month‐old mice with acute exercise. (C) Volcano plot of 24‐month‐old phospho‐proteome highlighting AMPKα2 (S491). (D–G) Age‐related changes in mitoAMPK⍺ expression and T172 and S491 phosphorylation in GA muscle. n = 4–7 per age and timepoint. (H–L) Age‐related changes in mitoAMPK expression. n = 6 per age. (M–O) Skeletal muscle lysates from 3‐month‐old mice ( n = 3) were combined, and aliquoted for three technical replicates per experiment and incubated with increasing concentrations of recombinant TRIM72, followed by mitochondrial isolations and immunoblot analysis of mitoAMPKα1 and mitoAMPKα2. ATP5A (Complex V) and MTCO1 (Complex IV) were assessed as mitochondrial protein controls. (P) Working model. Data presented as mean ± SD. Main or interaction effects from Two‐way ANOVA (E–G) or one‐way Anova (I–L, N, O) are reported in each panel where applicable. * p < 0.05; ** p < 0.01; *** p < 0.001.

Article Snippet: Western blotting was performed as described previously (Laker et al. ; Drake et al. ), using the following primary antibodies (1:1000 dilution): LC3I/II (CST #4108), phospho‐AMPK Thr172 (CST #2535), AMPKα1/2 (CST #2532), AMPKβ2 (Novus Biologicals #92286), AMPKγ1 (Abcam #ab32508), VDAC (CST #4866), α‐tubulin (Abcam #11304), and OXPHOS (Abcam #110413).

Techniques: Phospho-proteomics, Analysis, Expressing, Incubation, Recombinant, Western Blot